rs267607184
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP2PP3_StrongPP5
The NM_000208.4(INSR):c.1177G>A(p.Gly393Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. G393G) has been classified as Likely benign.
Frequency
Consequence
NM_000208.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
INSR | NM_000208.4 | c.1177G>A | p.Gly393Arg | missense_variant | 5/22 | ENST00000302850.10 | |
INSR | NM_001079817.3 | c.1177G>A | p.Gly393Arg | missense_variant | 5/21 | ||
INSR | XM_011527988.3 | c.1177G>A | p.Gly393Arg | missense_variant | 5/22 | ||
INSR | XM_011527989.4 | c.1177G>A | p.Gly393Arg | missense_variant | 5/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
INSR | ENST00000302850.10 | c.1177G>A | p.Gly393Arg | missense_variant | 5/22 | 1 | NM_000208.4 | A2 | |
INSR | ENST00000341500.9 | c.1177G>A | p.Gly393Arg | missense_variant | 5/21 | 1 | P3 | ||
INSR | ENST00000598216.1 | n.1152G>A | non_coding_transcript_exon_variant | 5/10 | 1 |
Frequencies
GnomAD3 genomes ? Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome ? Cov.: 31
ClinVar
Submissions by phenotype
Leprechaunism syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 05, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at